World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
122
Citations
62824
World Ranking
494
National Ranking
51

Medicine

D-Index
125
Citations
66160
World Ranking
3056
National Ranking
309

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Jane F. Apperley is affiliated with Imperial College London in the United Kingdom. Their research primarily falls within the field of Medicine, with a particular focus on Hematology, Genetics, Public Health, Environmental and Occupational Health, Oncology, and Rheumatology.

The scientist's work covers several specific topics, including:

  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Click Chemistry and Applications
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Jane F. Apperley has contributed to numerous publications in leading scientific journals, with frequent appearance in the following venues:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • British Journal of Haematology
  • Bone Marrow Transplantation

Their recent papers include the following publications:

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms, 2022, Leukemia
  • European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia, 2020, Leukemia
  • A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs, 2021, Blood
  • COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey, 2021, Leukemia
  • Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial, 2021, Blood

Collaboration is an important aspect of their research activities. Frequent co-authors working alongside Jane F. Apperley include:

  • Jorge E. Cortés
  • Michael J. Mauro
  • Andreas Hochhaus
  • Dragana Milojković
  • Michael W. Deininger

Best Publications

  • European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    Michele Baccarani;Michael W. Deininger;Gianantonio Rosti;Andreas Hochhaus

  • Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

    Joan BladÉ;Diana Samson;Donna Reece;Jane Apperley

  • Defining the intensity of conditioning regimens: working definitions.

    Andrea Bacigalupo;Karen Ballen;Doug Rizzo;Sergio Giralt

  • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Michele Baccarani;Giuseppe Saglio;John Goldman;Andreas Hochhaus

  • Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

    Michele Baccarani;Jorge Cortes;Fabrizio Pane;Dietger Niederwieser

  • A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    Jorge E. Cortes;D. W. Kim;J. Pinilla-Ibarz;P. Le Coutre

  • European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    Andreas Hochhaus;Michele Baccarani;Richard T. Silver;Charles A. Schiffer

  • Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

    David Marin;Alexandra Bazeos;Francois Xavier Mahon;Lina Eliasson

  • Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation

    A. Gratwohl;J. Hermans;J. Goldman;W. Arcese

  • Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia

    Jane F Apperley

  • Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity

    Simone Wahl;Alexander Drong;Benjamin Lehne;Marie Loh;Marie Loh;Marie Loh

  • Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

    Andreas Hochhaus;Hagop M. Kantarjian;Michele Baccarani;Jeffrey H. Lipton

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.

    Jane F. Apperley;Martine Gardembas;Junia V. Melo;Robin Russell-Jones

  • Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis

    Hugues de Lavallade;Jane F. Apperley;Jamshid S. Khorashad;Dragana Milojkovic

  • Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.

    Antonio Galleu;Yanira Riffo-Vasquez;Cristina Trento;Cara Lomas

  • Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors

    David Marin;Amr R. Ibrahim;Claire Lucas;Gareth Gerrard

  • Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

    Mahmoud al-Jurf;Mahmoud al-Jurf;Francisco Aranha;Francisco Aranha;Claudio Annasetti;Jane F. Apperley;Jane F. Apperley

  • Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis

    Jorge E Cortes;Philippe Rousselot;Dong Wook Kim;Ellen Ritchie

  • Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

    C M Shipman;Michael John Rogers;J F Apperley;R G Russell

Frequent Co-Authors

John M. Goldman
John M. Goldman Imperial College London
Richard Szydlo
Richard Szydlo Imperial College London
Jorge E. Cortes
Jorge E. Cortes Augusta University
Dietger Niederwieser
Dietger Niederwieser Leipzig University
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Alois Gratwohl
Alois Gratwohl University of Basel
Francesco Dazzi
Francesco Dazzi King's College London
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Michele Baccarani
Michele Baccarani University of Bologna
Michael W. Deininger
Michael W. Deininger University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine isn’t limited to becoming a physician. There are a variety of online degree programs that provide flexible options for students interested in healthcare. Many aspiring nurse practitioners pursue cheapest dnp online programs to earn a Doctor of Nursing Practice degree without the high costs of traditional, on-campus study.

If pharmacy interests you, accredited online pharmacy schools offer advanced degrees designed for busy professionals. For those interested in data management and healthcare technology, a him bachelor's degree online can open doors to roles in managing patient records and healthcare IT systems.

Additionally, students seeking entry-level opportunities can consider online medical billing and coding courses, which provide the training needed to support healthcare facilities with administrative and insurance-related tasks. These alternative pathways make it easier for individuals to launch or advance a career in healthcare on their own schedule.

Best Scientists Citing Jane F. Apperley

Trending Scientists

Recently Published Articles